Your HDL is 26 mg/dL — low, but expected on blast. Your LDL is 145 mg/dL — elevated, also expected. But your triglycerides are 250 mg/dL, and that is a different category of problem. Unlike HDL suppression and LDL elevation, high triglycerides on cycle tell a story about metabolic stress that goes beyond "standard AAS dyslipidemia" and points to a more urgent set of interventions.
Triglycerides vs. Cholesterol: Different Problems
Most AAS users think of "lipids" as a single category, but triglycerides and cholesterol are metabolically distinct. Cholesterol is structural — it builds cell membranes and hormones. Triglycerides are energy storage — they are what your liver packages into VLDL particles and sends to your tissues for storage or fuel.
This distinction matters because the drivers are different. High LDL on AAS is primarily driven by androgen receptor-mediated changes in hepatic LDL receptor expression. High triglycerides are driven by increased VLDL production in the liver — which is fueled by carbohydrate intake, oral AAS hepatotoxicity, and insulin resistance. A user with high LDL and normal triglycerides has a different problem than a user with both high LDL and high triglycerides.
Triglycerides
What Makes Triglycerides Rise on AAS
Four factors consistently drive triglyceride elevation in AAS users, and identifying which one applies to you determines the most effective intervention.
Oral AAS. 17-alpha-alkylated orals are the single strongest driver. The first-pass hepatic effect increases VLDL production directly. Anavar, Winstrol, and Anadrol users consistently show the highest triglyceride values. The effect is dose-dependent and rapid — triglycerides rise within days of starting an oral.
Growth hormone. GH induces insulin resistance in a dose-dependent manner, and insulin resistance is a direct driver of VLDL overproduction. Users on 4+ IU of GH per day commonly see triglycerides rise by 30-60 mg/dL. This effect is independent of the AAS component and additive when both are used together.
High-dose testosterone. Testosterone above 500 mg per week increases hepatic lipase activity and VLDL production. The effect is modest compared to orals but becomes significant at higher doses and when combined with other triglyceride-raising factors.
High-carbohydrate diet. A diet high in refined carbohydrates amplifies VLDL production in the liver. For users already on orals, a high-carb diet can push triglycerides 50-100 mg/dL higher than a lower-carb approach with the same compound regimen. This is the most modifiable factor and the one most often overlooked.
The TG/HDL Ratio: Predicting Small Dense LDL
The ratio of triglycerides to HDL is one of the most powerful predictors of atherogenic dyslipidemia — specifically the presence of small, dense LDL particles. When the ratio exceeds 3.5 (in mg/dL units), it indicates that your LDL particles are predominantly the small, dense type that is most damaging to arterial health. This is because high triglycerides drive the production of VLDL, which is then remodeled into small, dense LDL through the action of cholesteryl ester transfer protein (CETP).
A practical example: triglycerides of 200 divided by HDL of 40 gives a ratio of 5.0 — well above the 3.5 threshold, indicating a high-risk particle distribution. The same triglycerides of 200 with an HDL of 70 gives a ratio of 2.9 — below threshold, suggesting larger, less dangerous LDL particles. This is why the TG/HDL ratio provides information that neither marker alone can give, and why tracking both together is more useful than tracking either in isolation.
TG/HDL Ratio: Quick Interpretation
Managing Triglycerides on Cycle
The most effective intervention for high triglycerides on AAS is removing or reducing the offending compound. Switching from an oral to an injectable equivalent resolves elevated triglycerides in the majority of cases — often within 2-3 weeks. If your triglycerides are elevated and you are using an oral, this should be your first intervention before adding supplements or changing diet.
Diet also matters. Reducing refined carbohydrates and added sugars consistently lowers triglycerides by 30-50% in compliant individuals, regardless of AAS use. This effect is independent of and additive to compound adjustment. A lower-carb approach (under 200 g/day from non-fiber sources) is the most effective dietary strategy for triglyceride reduction on cycle.
Omega-3 fatty acids at 3-4 grams of EPA plus DHA per day reduce triglycerides by 20-30% on average — the most evidence-supported supplement for this specific indication. The effect is dose-dependent, with higher doses producing greater reductions. Fish oil, krill oil, and algal oil are all effective; the key is the total EPA plus DHA content, not the source.